MRCP UK
Share
Welcome to MRCP UK – Your Trusted Study Hub! This group is dedicated to medical professionals preparing for the MRCP (UK) exams – Part 1, Part 2, and PACES.
CKD + need for a glucose-lowering drug with low hypoglycemia risk → think DPP-4 inhibitor, especially Linagliptin.
CKD + desire to slow kidney disease progression and reduce cardiovascular events → think SGLT2 inhibitor first (if eGFR permits).
10/06/2026
Metformin
Hypertension + hypokalemia
→ Think mineralocorticoid excess, especially:
Primary Hyperaldosteronism
Secondary hyperaldosteronism
Cushing Syndrome
Apparent mineralocorticoid excess (e.g., liquorice ingestion)
Click here to claim your Sponsored Listing.
Category
Address
36441
